Astrana Health updates corporate presentation, reiterates FY2026 guidance and $267.5M adj. EBITDA midpoint

Astrana Health updated its corporate presentation highlighting platform scale, FY2026 guidance and a $267.5M adjusted EBITDA midpoint.Key Highlights:Original SEC Filing: Astrana Health, Inc. [ ASTH ] - 8-K - Sep. 15, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying…